← Aehr Test Systems overview

Aehr Test Systems vs FormFactor: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Aehr Test Systems (AEHR)

Q3 2026
▲3▼1

Aehr's AI-driven turnaround: record bookings, but valuation and insider selling raise flags

  • Record bookings and backlog Aehr reported record bookings of $60.7 million and a backlog of $100.6 million, supporting fiscal 2027 revenue guidance of $130–150 million, nearly triple last year's level.

    This is the core new positive development that drove the quarter.

  • AI and silicon photonics demand AI processors and silicon photonics now account for 91–95% of revenue, replacing EV silicon carbide dependence, with repeat orders including $6 million from a hyperscale customer.

    Shows the successful shift to a hot new market, a key driver of the turnaround.

  • Earnings beat and profitability outlook Earnings beat estimates, and management expects a return to profitability, signaling improving financial health.

    Confirms the turnaround is translating into better financial results.

  • Valuation and insider selling risks The stock trades at roughly 81 times trailing sales, analysts see over 40% downside, and the CEO sold $5.2 million in shares—about 20% of his trust holdings—while the company still reports net losses.

    Highlights the major counterweight that could pressure the stock despite operational success.

August 2026
▲3▼1

Aehr's AI test orders and record backlog drive growth, but valuation and insider selling raise caution

  • Record backlog and strong fiscal 2027 guidance Aehr guided fiscal 2027 revenue to $130–$150 million, up to 200% growth, after record bookings of $60.7 million pushed backlog to $100.6 million. That backlog already covers 77% of the low end, giving investors confidence in future sales and pushing the stock up.

    This is the core new financial outlook that directly drives investor expectations for future revenue and profit.

  • Diversification into AI and silicon photonics pays off Aehr now gets 95% of revenue outside EV silicon carbide, with AI processors and silicon photonics making up 91% of last quarter's sales. New orders, including a $22 million AI processor order and silicon photonics production orders, show concrete demand and reduce reliance on the EV market.

    It shows the company successfully shifted its business to faster-growing AI markets, which supports higher future revenue.

  • New $6M follow-on order from hyperscale AI customer Aehr won about $6 million in follow-on orders from its lead hyperscale customer for testing next-generation AI processors. The equipment will ship over six months to a Taiwan partner, adding near-term revenue and confirming that demand from big AI chip makers is real and repeating.

    This is a fresh order that directly adds to revenue and validates the company's growth story with a major customer.

  • CEO sells $5.2 million in shares, valuation stretched CEO Gayn Erickson sold $5.2 million of stock, cutting his trust holdings by 20%, while the company still reports a net loss. The stock trades at a very high price-to-sales ratio, and insider selling can signal that even management sees the shares as fully valued, which may weigh on the price.

    It provides a real counterweight: insider selling and high valuation could limit further gains or trigger a pullback.

Latest
▲3▼1

Aehr's AI test orders and record backlog drive growth, but valuation and insider selling raise caution

  • Record backlog and strong fiscal 2027 guidance Aehr guided fiscal 2027 revenue to $130–$150 million, up to 200% growth, after record bookings of $60.7 million pushed backlog to $100.6 million. That backlog already covers 77% of the low end, giving investors confidence in future sales and pushing the stock up.

    This is the core new financial outlook that directly drives investor expectations for future revenue and profit.

  • Diversification into AI and silicon photonics pays off Aehr now gets 95% of revenue outside EV silicon carbide, with AI processors and silicon photonics making up 91% of last quarter's sales. New orders, including a $22 million AI processor order and silicon photonics production orders, show concrete demand and reduce reliance on the EV market.

    It shows the company successfully shifted its business to faster-growing AI markets, which supports higher future revenue.

  • New $6M follow-on order from hyperscale AI customer Aehr won about $6 million in follow-on orders from its lead hyperscale customer for testing next-generation AI processors. The equipment will ship over six months to a Taiwan partner, adding near-term revenue and confirming that demand from big AI chip makers is real and repeating.

    This is a fresh order that directly adds to revenue and validates the company's growth story with a major customer.

  • CEO sells $5.2 million in shares, valuation stretched CEO Gayn Erickson sold $5.2 million of stock, cutting his trust holdings by 20%, while the company still reports a net loss. The stock trades at a very high price-to-sales ratio, and insider selling can signal that even management sees the shares as fully valued, which may weigh on the price.

    It provides a real counterweight: insider selling and high valuation could limit further gains or trigger a pullback.

July 2026
▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

FormFactor Inc (FORM)

Q3 2026
▲2▼2

FormFactor Hits $1B Run Rate on AI Demand, But Volatility Persists

  • Record Q2 results and raised guidance FormFactor reported record Q2 revenue of $258.2 million and earnings per share of $0.82, beating expectations. Management raised Q3 guidance to about $270 million, pushing the stock up 25.6% as annualized revenue passed $1 billion.

    This is the core positive event that drove the stock higher during the period.

  • New growth drivers: co-packaged optics and HBM4 Demand accelerated for co-packaged optics, and FormFactor gained market share in HBM4 memory testing with its SmartMatrix product. Deutsche Bank initiated coverage with a buy rating, highlighting these opportunities.

    These are new positive developments that support future revenue growth.

  • July selloff on China competition and AI doubts A semiconductor selloff in July, driven by concerns over Chinese memory maker CXMT and doubts about AI demand, cut FormFactor shares by 9–11%. This reflected broader sector fears rather than company-specific issues.

    This was a major negative force that caused significant price drops during the period.

  • TSMC capex and AI safety concerns TSMC's increased capital spending raised worries about margins and free cash flow, while calls for AI safety pauses from Anthropic, OpenAI, and SpaceX leaders sparked a 7.6% drop on fears of slower deployment.

    These events created downward pressure on the stock, offsetting some gains.

August 2026
▲3▼1

AI demand swings and analyst resets drive FormFactor's volatile period

  • AI demand surge lifts chip stocks Anthropic's revenue jumped more than 14-fold to over $11.5 billion, signaling strong AI infrastructure spending. FormFactor shares rose 5.4% as investors bet on continued demand for chip testing equipment used in AI chips.

    Shows a key demand driver that pushed FORM up during the period.

  • Strong Q2 results and peer momentum FormFactor reported revenue of $258.2 million, up 31.9% year on year and 7.6% above expectations, with the stock up 34.7%. Applied Materials and other chip equipment peers also posted record results, reinforcing sector strength.

    Highlights FormFactor's own strong earnings and positive sector backdrop.

  • AI safety concerns trigger sell-off CEOs of Anthropic, OpenAI, and SpaceX called for a slowdown in frontier AI model development, spooking investors. FormFactor fell 7.6% as Citigroup warned that any pause in AI deployments could pressure chipmakers reliant on rapid infrastructure expansion.

    Shows a real counterweight: regulatory/safety fears that could dampen AI-driven demand.

  • Deutsche Bank initiates with buy rating Deutsche Bank started coverage of FormFactor with a buy rating, citing rising chip testing intensity and its position as the second source of probe cards for Nvidia's GPUs at TSMC. The stock rose 1% on the news.

    New analyst endorsement highlights FormFactor's strategic role in AI chip testing.

Latest
▲3▼1

AI demand swings and analyst resets drive FormFactor's volatile period

  • AI demand surge lifts chip stocks Anthropic's revenue jumped more than 14-fold to over $11.5 billion, signaling strong AI infrastructure spending. FormFactor shares rose 5.4% as investors bet on continued demand for chip testing equipment used in AI chips.

    Shows a key demand driver that pushed FORM up during the period.

  • Strong Q2 results and peer momentum FormFactor reported revenue of $258.2 million, up 31.9% year on year and 7.6% above expectations, with the stock up 34.7%. Applied Materials and other chip equipment peers also posted record results, reinforcing sector strength.

    Highlights FormFactor's own strong earnings and positive sector backdrop.

  • AI safety concerns trigger sell-off CEOs of Anthropic, OpenAI, and SpaceX called for a slowdown in frontier AI model development, spooking investors. FormFactor fell 7.6% as Citigroup warned that any pause in AI deployments could pressure chipmakers reliant on rapid infrastructure expansion.

    Shows a real counterweight: regulatory/safety fears that could dampen AI-driven demand.

  • Deutsche Bank initiates with buy rating Deutsche Bank started coverage of FormFactor with a buy rating, citing rising chip testing intensity and its position as the second source of probe cards for Nvidia's GPUs at TSMC. The stock rose 1% on the news.

    New analyst endorsement highlights FormFactor's strategic role in AI chip testing.

July 2026
▲2▼2

Record Q2 and raised outlook drive FormFactor higher despite sector selloff

  • Record Q2 results and raised Q3 guidance FormFactor reported record Q2 revenue of $258.2 million and EPS of $0.82, beating expectations, and guided Q3 to about $270 million and $0.86 EPS. The stock jumped 25.6% as the annualized revenue run rate passed $1 billion, showing the AI testing boom is translating into real profits.

    This is the biggest new event of the period and directly explains the stock's sharp move.

  • Accelerating co-packaged optics and HBM4 share gains Management said demand for co-packaged optics is accelerating, with full-year 2026 revenue now expected to significantly exceed the initial $20 million forecast. FormFactor also gained market share in HBM4 using its SmartMatrix technology, expanding its AI exposure beyond memory into networking and custom chips.

    This shows new growth drivers that support future revenue and justify the stock's premium valuation.

  • Sector selloff on China competition and AI demand doubts On July 29, semiconductor stocks fell sharply, with FormFactor dropping 9-11%, amid fears of increased competition from China and doubts about the sustainability of AI demand. Reports of China's progress in advanced chip manufacturing and the strong debut of Chinese memory maker CXMT fueled oversupply and pricing concerns.

    This is a real counterweight that pressured the stock just before earnings, showing the risks investors are weighing.

  • TSMC capex reset triggered semiconductor selloff On July 16, FormFactor fell 6.9% after TSMC raised its capital expenditure guidance, sparking a broad semiconductor selloff. Investors worried that rising costs for AI manufacturing capacity would pressure free cash flow and margins across the sector, even though TSMC also lifted its revenue outlook.

    This event shows how broader industry cost concerns can drag FormFactor down, even when its own business is strong.

▲2▼2

Record Q2 and raised outlook drive FormFactor higher despite sector selloff

  • Record Q2 results and raised Q3 guidance FormFactor reported record Q2 revenue of $258.2 million and EPS of $0.82, beating expectations, and guided Q3 to about $270 million and $0.86 EPS. The stock jumped 25.6% as the annualized revenue run rate passed $1 billion, showing the AI testing boom is translating into real profits.

    This is the biggest new event of the period and directly explains the stock's sharp move.

  • Accelerating co-packaged optics and HBM4 share gains Management said demand for co-packaged optics is accelerating, with full-year 2026 revenue now expected to significantly exceed the initial $20 million forecast. FormFactor also gained market share in HBM4 using its SmartMatrix technology, expanding its AI exposure beyond memory into networking and custom chips.

    This shows new growth drivers that support future revenue and justify the stock's premium valuation.

  • Sector selloff on China competition and AI demand doubts On July 29, semiconductor stocks fell sharply, with FormFactor dropping 9-11%, amid fears of increased competition from China and doubts about the sustainability of AI demand. Reports of China's progress in advanced chip manufacturing and the strong debut of Chinese memory maker CXMT fueled oversupply and pricing concerns.

    This is a real counterweight that pressured the stock just before earnings, showing the risks investors are weighing.

  • TSMC capex reset triggered semiconductor selloff On July 16, FormFactor fell 6.9% after TSMC raised its capital expenditure guidance, sparking a broad semiconductor selloff. Investors worried that rising costs for AI manufacturing capacity would pressure free cash flow and margins across the sector, even though TSMC also lifted its revenue outlook.

    This event shows how broader industry cost concerns can drag FormFactor down, even when its own business is strong.

Q2 2026
▲3▼1

AI chip demand drives FormFactor's record results, but memory and China risks loom

  • Record Q1 revenue and profit surge FormFactor reported Q1 2026 revenue up 32% to $226 million and earnings per share up 349% to $0.46, with management expecting a record Q2 driven by DRAM probe card sales. This shows the company is benefiting strongly from AI chip testing demand, pushing the stock up.

    This is the core fundamental driver of FormFactor's business performance and directly explains why the stock is moving.

  • AI capex boom boosts testing demand Zacks highlighted FormFactor as a top pick for the AI infrastructure spending surge, with cloud providers expected to spend $700 billion in 2026. As AI chips become more complex, demand for FormFactor's testing solutions rises, supporting the stock price.

    This points to a broad, ongoing demand driver that underpins FormFactor's growth outlook.

  • Memory slowdown and profit-taking hit sector A report that SK Hynix is slowing HBM expansion triggered a broad AI-chip selloff, with FormFactor falling 8.4%. Later, Samsung's record profit led to profit-taking, and news of DeepSeek's own AI chip raised fears of reduced demand for test equipment, sending FormFactor down 10.2%.

    These events represent real counterweights that have pressured FormFactor's stock during the period.

  • China Nvidia import hopes lift test equipment stocks Reports that China may allow limited imports of Nvidia's H200 chips sparked a rally in semiconductor manufacturing stocks, with FormFactor jumping 9.5%. Easing restrictions could boost demand for advanced chip testing and packaging equipment, benefiting FormFactor.

    This is a new positive catalyst that directly lifted FormFactor's stock and could improve future demand.

June 2026
▲3▼1

AI chip demand drives FormFactor's record results, but memory and China risks loom

  • Record Q1 revenue and profit surge FormFactor reported Q1 2026 revenue up 32% to $226 million and earnings per share up 349% to $0.46, with management expecting a record Q2 driven by DRAM probe card sales. This shows the company is benefiting strongly from AI chip testing demand, pushing the stock up.

    This is the core fundamental driver of FormFactor's business performance and directly explains why the stock is moving.

  • AI capex boom boosts testing demand Zacks highlighted FormFactor as a top pick for the AI infrastructure spending surge, with cloud providers expected to spend $700 billion in 2026. As AI chips become more complex, demand for FormFactor's testing solutions rises, supporting the stock price.

    This points to a broad, ongoing demand driver that underpins FormFactor's growth outlook.

  • Memory slowdown and profit-taking hit sector A report that SK Hynix is slowing HBM expansion triggered a broad AI-chip selloff, with FormFactor falling 8.4%. Later, Samsung's record profit led to profit-taking, and news of DeepSeek's own AI chip raised fears of reduced demand for test equipment, sending FormFactor down 10.2%.

    These events represent real counterweights that have pressured FormFactor's stock during the period.

  • China Nvidia import hopes lift test equipment stocks Reports that China may allow limited imports of Nvidia's H200 chips sparked a rally in semiconductor manufacturing stocks, with FormFactor jumping 9.5%. Easing restrictions could boost demand for advanced chip testing and packaging equipment, benefiting FormFactor.

    This is a new positive catalyst that directly lifted FormFactor's stock and could improve future demand.

▲3▼1

AI chip demand drives FormFactor's record results, but memory and China risks loom

  • Record Q1 revenue and profit surge FormFactor reported Q1 2026 revenue up 32% to $226 million and earnings per share up 349% to $0.46, with management expecting a record Q2 driven by DRAM probe card sales. This shows the company is benefiting strongly from AI chip testing demand, pushing the stock up.

    This is the core fundamental driver of FormFactor's business performance and directly explains why the stock is moving.

  • AI capex boom boosts testing demand Zacks highlighted FormFactor as a top pick for the AI infrastructure spending surge, with cloud providers expected to spend $700 billion in 2026. As AI chips become more complex, demand for FormFactor's testing solutions rises, supporting the stock price.

    This points to a broad, ongoing demand driver that underpins FormFactor's growth outlook.

  • Memory slowdown and profit-taking hit sector A report that SK Hynix is slowing HBM expansion triggered a broad AI-chip selloff, with FormFactor falling 8.4%. Later, Samsung's record profit led to profit-taking, and news of DeepSeek's own AI chip raised fears of reduced demand for test equipment, sending FormFactor down 10.2%.

    These events represent real counterweights that have pressured FormFactor's stock during the period.

  • China Nvidia import hopes lift test equipment stocks Reports that China may allow limited imports of Nvidia's H200 chips sparked a rally in semiconductor manufacturing stocks, with FormFactor jumping 9.5%. Easing restrictions could boost demand for advanced chip testing and packaging equipment, benefiting FormFactor.

    This is a new positive catalyst that directly lifted FormFactor's stock and could improve future demand.